FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052265257> ?p ?o ?g. }

• W2052265257 endingPage "1204" @default.
• W2052265257 startingPage "1192" @default.
• W2052265257 abstract "The DNA methyltransferase (DNMT) inhibitory drugs such as 5-azacytidine induce DNA hypomethylation by inhibiting DNA methyltransferases. While clinically effective, DNMT inhibitors are not curative. A combination with cytotoxic drugs might be beneficial, but this is largely unexplored. In the present study, we analyzed potential synergisms between cytotoxic drugs and 5-azacytidine in acute myeloid leukemia (AML) and non-small cell lung cancer (NSCLC) cells. Lung cancer and leukemia cell lines were exposed to low doses of 5-azacytidine with varying doses of cytarabine or etoposide for AML cells (U937 and HL60) as well as cisplatin or gemcitabine for NSCLC cells (A549 and HTB56) for 48 h. Drug interaction and potential synergism was analyzed according to the Chou-Talalay algorithm. Further analyses were based on soft agar colony formation assays, active caspase-3 staining and BrdU incorporation flow cytometry. To identify effects on DNA methylation patterns, we performed genome wide DNA methylation analysis using 450K bead arrays. Azacytidine at low doses was synergistic with cytotoxic drugs in NSCLC and in AML cell lines. Simultaneous exposure to 5-azacytidine with cytotoxic drugs showed strong synergistic activity. In colony formation assays these synergisms were repeatedly verified for 5-azacytidine (25 nM) with low doses of anticancer agents. 5-azacytidine neither affected the cell cycle nor increased apoptosis. 450K methylation bead arrays revealed 1,046 CpG sites in AML and 1,778 CpG sites in NSCLC cells with significant DNA hypomethylation (24-h exposure) to 5-azacytidine combined with the cytotoxic drugs. These CpG-sites were observed in the candidate tumor-suppressor genes MGMT and THRB. Additional incubation time after 24-h treatment led to a 4.1-fold increase of significant hypomethylated CpG-sites in NSCLC cells. These results suggest that the addition of DNA demethylating agents to cytotoxic anticancer drugs exhibits synergistic activity in AML and NSCLC. Dysregulation of an equilibrium of DNA methylation in cancer cells might increase the susceptibility for cytotoxic drugs." @default.
• W2052265257 created "2016-06-24" @default.
• W2052265257 creator A5025105470 @default.
• W2052265257 creator A5028226736 @default.
• W2052265257 creator A5028388949 @default.
• W2052265257 creator A5031124801 @default.
• W2052265257 creator A5054956690 @default.
• W2052265257 creator A5056684984 @default.
• W2052265257 creator A5063597334 @default.
• W2052265257 creator A5071328043 @default.
• W2052265257 creator A5075002293 @default.
• W2052265257 creator A5078614065 @default.
• W2052265257 creator A5083057715 @default.
• W2052265257 date "2014-12-10" @default.
• W2052265257 modified "2023-09-30" @default.
• W2052265257 title "5-Azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation" @default.
• W2052265257 cites W1504303645 @default.
• W2052265257 cites W1577875429 @default.
• W2052265257 cites W1965262464 @default.
• W2052265257 cites W1969848098 @default.
• W2052265257 cites W1978569657 @default.
• W2052265257 cites W1982356313 @default.
• W2052265257 cites W1984731449 @default.
• W2052265257 cites W1991858306 @default.
• W2052265257 cites W1992401642 @default.
• W2052265257 cites W2005166484 @default.
• W2052265257 cites W2023301779 @default.
• W2052265257 cites W2024819383 @default.
• W2052265257 cites W2025004154 @default.
• W2052265257 cites W2029874395 @default.
• W2052265257 cites W2032004540 @default.
• W2052265257 cites W2035462330 @default.
• W2052265257 cites W2040257851 @default.
• W2052265257 cites W2045468934 @default.
• W2052265257 cites W2047089740 @default.
• W2052265257 cites W2051956047 @default.
• W2052265257 cites W2054823635 @default.
• W2052265257 cites W2059437495 @default.
• W2052265257 cites W2060446375 @default.
• W2052265257 cites W2063607020 @default.
• W2052265257 cites W2068170334 @default.
• W2052265257 cites W2077945404 @default.
• W2052265257 cites W2085246002 @default.
• W2052265257 cites W2085972813 @default.
• W2052265257 cites W2086894556 @default.
• W2052265257 cites W2089995356 @default.
• W2052265257 cites W2094044442 @default.
• W2052265257 cites W2095430690 @default.
• W2052265257 cites W2098903417 @default.
• W2052265257 cites W2106658124 @default.
• W2052265257 cites W2106833395 @default.
• W2052265257 cites W2121417064 @default.
• W2052265257 cites W2138411138 @default.
• W2052265257 cites W2139077902 @default.
• W2052265257 cites W2140531885 @default.
• W2052265257 cites W2141410747 @default.
• W2052265257 cites W2145287289 @default.
• W2052265257 cites W2147516356 @default.
• W2052265257 cites W2149683741 @default.
• W2052265257 cites W2151635781 @default.
• W2052265257 cites W2159955284 @default.
• W2052265257 cites W2168473428 @default.
• W2052265257 cites W3143681446 @default.
• W2052265257 doi "https://doi.org/10.3892/ijo.2014.2792" @default.
• W2052265257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25501798" @default.
• W2052265257 hasPublicationYear "2014" @default.
• W2052265257 type Work @default.
• W2052265257 sameAs 2052265257 @default.
• W2052265257 citedByCount "29" @default.
• W2052265257 countsByYear W20522652572015 @default.
• W2052265257 countsByYear W20522652572016 @default.
• W2052265257 countsByYear W20522652572017 @default.
• W2052265257 countsByYear W20522652572018 @default.
• W2052265257 countsByYear W20522652572020 @default.
• W2052265257 countsByYear W20522652572021 @default.
• W2052265257 countsByYear W20522652572022 @default.
• W2052265257 crossrefType "journal-article" @default.
• W2052265257 hasAuthorship W2052265257A5025105470 @default.
• W2052265257 hasAuthorship W2052265257A5028226736 @default.
• W2052265257 hasAuthorship W2052265257A5028388949 @default.
• W2052265257 hasAuthorship W2052265257A5031124801 @default.
• W2052265257 hasAuthorship W2052265257A5054956690 @default.
• W2052265257 hasAuthorship W2052265257A5056684984 @default.
• W2052265257 hasAuthorship W2052265257A5063597334 @default.
• W2052265257 hasAuthorship W2052265257A5071328043 @default.
• W2052265257 hasAuthorship W2052265257A5075002293 @default.
• W2052265257 hasAuthorship W2052265257A5078614065 @default.
• W2052265257 hasAuthorship W2052265257A5083057715 @default.
• W2052265257 hasBestOaLocation W20522652571 @default.
• W2052265257 hasConcept C104317684 @default.
• W2052265257 hasConcept C121608353 @default.
• W2052265257 hasConcept C150194340 @default.
• W2052265257 hasConcept C154317977 @default.
• W2052265257 hasConcept C190727270 @default.
• W2052265257 hasConcept C202751555 @default.
• W2052265257 hasConcept C2776239401 @default.
• W2052265257 hasConcept C2776694085 @default.
• W2052265257 hasConcept C2778119113 @default.

• next